PDI

PDI
Share

At PDI, we never forget who we are all working for. That’s why we offer a broad range of evidence-based, market leading Interventional Care, Environment of Care, and Patient Care solutions, all designed to help reduce preventable infections, control healthcare costs, and ultimately help save lives. It’s all part of our passion to Be The Difference®, every day.


PDI

 •  June 7

What You'll Find We are evolving rapidly to do more and offer more in the fight against preventable infections. Check this page to stay informed about important PDI news and events.

PDI

 •  April 18

Prevantics® brand has them both covered.
Skin: Antiseptic Swabstick and Maxi Swabstick’s 7 day continued antimicrobial activity correlates well with many dressing change protocols.
Site: Device Swab’s 5 second scrub- 5 second dry time improves compliance.
Request your FREE sample kit at www.pdihc.com/SkinPlusSite
Attending INS? Visit our booth...

PDI

 •  March 30

In February, the World Health Organization (WHO) published their first list of antibiotic-resistant “priority pathogens”. This is a list of the most concerning bacteria that pose the “greatest threat to human health”. This list is divided into three levels of antibiotic-resistant bacteria based on their significance and potential impact to global...

PDI

 •  January 24

Dr. Rutala and Dr. Weber join as exclusive consultants to help shape disinfection, antisepsis and hand hygiene efforts Orangeburg, NY – January 17, 2017 – PDI, a leader in infection prevention products and solutions, announces an exclusive relationship with two of the world’s leading experts in infection prevention and epidemiology, Bill Rutala,...

PDI

 •  January 10

Orangeburg, NY – January 10, 2017 – PDI, a leader in infection prevention products and solutions, announces the appointment of Brent Boucher to a newly created role, Executive in Residence, for the Infection Prevention Business Unit. As Executive in Residence, Brent will lead key projects and initiatives critical to the company’s growth and...

PDI

 •  January 4

Chlorhexidine Gluconate for the Prevention of Central Line-Associated Bloodstream Infections - Current Science Chlorhexidine gluconate (CHG) is an antibacterial antiseptic with the ability to inhibit and kill bacteria associated with healthcare-associated infections (HAIs). In the last two decades, investigators have researched the use of CHG for...

PDI

 •  January 4

Chlorhexidine Gluconate for the Prevention of Central Line-Associated Bloodstream Infections - Current Science Chlorhexidine gluconate (CHG) is an antibacterial antiseptic with the ability to inhibit and kill bacteria associated with healthcare-associated infections (HAIs). In the last two decades, investigators have researched the use of CHG for...

PDI

 •  November 11, 2016

A recent article entitled Mechanisms of increased resistance to chlorhexidine and cross-resistance to colistin following exposure of Klebsiella pneumoniae clinical isolates to chlorhexidinepublished in the Antimicrobial Agents and Chemotherapy journal showed how researchers induced resistance to chlorhexidine (CHG) in Klebsiella pneumoniae, and...

PDI

 •  October 27, 2016

Outbreaks in Dialysis: Review and Prevention Thu, Dec 8, 2016 2:00 PM - 3:00 PM Eastern Daylight Time In this educational webinar, participants will review outbreaks associated with dialysis in the last ten years. In addition, infection prevention breaches that may trigger a citation during the survey process will be discussed, as well as...

PDI

 •  October 12, 2016

Leaders in infection prevention and thermoplastic technology conduct stress-cracking study to unravel compatibility issues Orangeburg, NY – October 12, 2016 – PDI, a leader in infection prevention products and solutions, along with SABIC, a global leader in thermoplastic technology, today announced the results of a joint study on environmental...